SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction

Published:2021-07 Issue: Volume:139 Page:111624
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Ahmed Ahmed S.,Mona Marwa M.,Abdel‑Kareem Mona A.,Elsisy Rasha A.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference50 articles.

1. Acute kidney injury [published correction appears];Levey;Ann. Intern. Med.,2018

2. Acute kidney injury;Farrar;Nurs. Clin. N. Am.,2018

3. Biomarkers of renal recovery after acute kidney injury. Biomarcadores de recuperação renal após lesão renal aguda;Gaião;Rev. Bras. Intensiv.,2017

4. Pediatric acute kidney injury;Fragasso;Contrib. Nephrol.,2018

5. Acute kidney injury in pregnancy;Vijayan;Curr. Opin. Crit. Care,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy;Pharmacology & Therapeutics;2023-09

2. The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes;Endokrynologia Polska;2023-06-30

3. Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system;American Journal of Physiology-Cell Physiology;2023-04-01

4. Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and the Incidence of Acute Kidney Injury in Taiwan;JAMA Network Open;2023-02-22

5. SGLT2 inhibitors protect cardiomyocytes from myocardial infarction: a direct mechanism?;Future Cardiology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3